Coldstream Capital Management Inc. Purchases 228 Shares of HCA Healthcare, Inc. $HCA

Coldstream Capital Management Inc. grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.2% in the second quarter, Holdings Channel reports. The firm owned 3,901 shares of the company’s stock after buying an additional 228 shares during the quarter. Coldstream Capital Management Inc.’s holdings in HCA Healthcare were worth $1,495,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Park Place Capital Corp increased its position in shares of HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after purchasing an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after buying an additional 2,698 shares during the last quarter. Cherokee Insurance Co purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $3,869,000. Swiss National Bank raised its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after purchasing an additional 23,100 shares during the period. Finally, Harrell Investment Partners LLC grew its holdings in HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 2.0%

HCA opened at $501.05 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $512.66. The company has a market capitalization of $114.34 billion, a P/E ratio of 19.37, a PEG ratio of 1.38 and a beta of 1.41. The stock’s fifty day moving average is $442.94 and its two-hundred day moving average is $402.39.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

Analysts Set New Price Targets

HCA has been the subject of a number of analyst reports. JPMorgan Chase & Co. increased their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Robert W. Baird boosted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Truist Financial lifted their price objective on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Royal Bank Of Canada raised their target price on shares of HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Finally, Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.